Eyad Elkord (E Elkord)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 45

Top Venues

Vaccines

Cancer immunology, immunotherapy : CII

Journal of immunology research

Cancers

University of Manchester

Al-Quds University (BSC)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Manchester

United Kingdom

Research Fellow/Group Leader

Paterson Institute for Cancer Research

United Kingdom

Postdoctoral Scientist

University of Salford

United Kingdom

Senior Lecturer

Hamad Bin Khalifa University Jul 14 2016

Qatar

Pricipal Investigator/Professor :: Qatar Biomedical Research Institute

United Arab Emirates University Sep 09 2012 - Oct 02 2016

United Arab Emirates

Associate Professor

Education History

Al-Quds University

Palestinian Territory

BSC

Cardiff University Oct 01 2001 - Dec 31 2004

United Kingdom

PHD

Publications

Murad Alahdal, Eyad Elkord
Non-coding RNAs in cancer immunotherapy: Predictive biomarkers and targets. Clinical and translational medicine 13 (9) (2023)
Alhasan Alsalman, Mohammad A Al-Mterin, Ala Abu-Dayeh, Ferial Alloush, Khaled A Murshed, Eyad Elkord
Associations of Complete Blood Count Parameters with Disease-Free Survival in Right- and Left-Sided Colorectal Cancer Patients. Journal of personalized medicine 12 (5) (2022)
Mohammad A Al-Mterin, Eyad Elkord
Myeloid-derived suppressor cells in colorectal cancer: prognostic biomarkers and therapeutic targets. Exploration of targeted anti-tumor therapy 3 (4) (2022)
Mohammad A Al-Mterin, Khaled A Murshed, Eyad Elkord
Correlations between Circulating and Tumor-Infiltrating CD4 + T Cell Subsets with Immune Checkpoints in Colorectal Cancer. Vaccines 10 (4) (2022)
Mohammad A Al-Mterin, Khaled A Murshed, Eyad Elkord
Correlations between Circulating and Tumor-Infiltrating CD4 + Treg Subsets with Immune Checkpoints in Colorectal Cancer Patients with Early and Advanced Stages. Vaccines 10 (9) (2022)
Murad Alahdal, Eyad Elkord
Promising use of immune cell-derived exosomes in the treatment of SARS-CoV-2 infections. Clinical and translational medicine 12 (8) (2022)
Alhasan Alsalman, Mohammad A Al-Mterin, Khaled A Murshed, Ferial Alloush, Samia T Al-Shouli, Salman M Toor, Eyad Elkord
Circulating and Tumor-Infiltrating Immune Checkpoint-Expressing CD8 + Treg/T Cell Subsets and Their Associations with Disease-Free Survival in Colorectal Cancer Patients. Cancers 14 (13) (2022)
Alhasan Alsalman, Mohammad A Al-Mterin, Eyad Elkord
Role of T Regulatory Cells and Myeloid-Derived Suppressor Cells in COVID-19. Journal of immunology research 2022 (2022)
Reem Saleh, Varun Sasidharan Nair, Khaled Murshed, Mohamed Abu Nada, Eyad Elkord, Ranad Shaheen
Transcriptome of CD8+ tumor-infiltrating T cells: a link between diabetes and colorectal cancer. Cancer immunology, immunotherapy : CII 70 (9) (2021)
Varun Sasidharan Nair, Reem Saleh, Salman M Toor, Farhan S Cyprian, Eyad Elkord
Metabolic reprogramming of T regulatory cells in the hypoxic tumor microenvironment. Cancer immunology, immunotherapy : CII 70 (8) (2021)
Salman M Toor, Varun Sasidharan Nair, Reem Saleh, Rowaida Z Taha, Khaled A Murshed, Mahmood Al-Dhaheri, Mahwish Khawar, Ayman A Ahmed, Mohamed A Kurer, Mohamed Abu Nada, Eyad Elkord
Transcriptome of Tumor-Infiltrating T Cells in Colorectal Cancer Patients Uncovered a Unique Gene Signature in CD4+ T Cells Associated with Poor Disease-Specific Survival. Vaccines 9 (4) (2021)
Aijaz Parray, Fayaz Ahmad Mir, Asmma Doudin, Ahmad Iskandarani, Mohammed Ibn-Mas'ud Danjuma, Rahim Ayadathil Thazhhe Kuni, Alaaedin Abdelmajid, Ibrahim Abdelhafez, Rida Arif, Mohammad Mulhim, Mohammad Abukhattab, Shoukat Rashhid Dar, Ala-Eddin Al Moustafa, Eyad Elkord, Abdul Latif Al Khal, Abdel-Naser Elzouki, Farhan Cyprian
SnoRNAs and miRNAs Networks Underlying COVID-19 Disease Severity. Vaccines 9 (10) (2021)
Salman M Toor, Varun Sasidharan Nair, Khaled A Murshed, Mohamed Abu Nada, Eyad Elkord
Tumor-Infiltrating Lymphoid Cells in Colorectal Cancer Patients with Varying Disease Stages and Microsatellite Instability-High/Stable Tumors. Vaccines 9 (1) (2021)
Reem Saleh, Varun Sasidharan Nair, Salman M Toor, Rowaida Z Taha, Khaled Murshed, Mahmood Al-Dhaheri, Mahwish Khawar, Mahir Abdulla Petkar, Mohamed Abu Nada, Fares Al-Ejeh, Eyad Elkord
Differential gene expression of tumor-infiltrating CD8+ T cells in advanced versus early-stage colorectal cancer and identification of a gene signature of poor prognosis. Journal for immunotherapy of cancer 8 (2) (2021)
Reem Saleh, Rowaida Z Taha, Salman M Toor, Varun Sasidharan Nair, Khaled Murshed, Mahwish Khawar, Mahmood Al-Dhaheri, Mahir Abdulla Petkar, Mohamed Abu Nada, Eyad Elkord
Expression of immune checkpoints and T cell exhaustion markers in early and advanced stages of colorectal cancer. Cancer immunology, immunotherapy : CII 69 (10) (2020)
Salman M Toor, Sarah Khalaf, Khaled Murshed, Mohamed Abu Nada, Eyad Elkord
Myeloid Cells in Circulation and Tumor Microenvironment of Colorectal Cancer Patients with Early and Advanced Disease Stages. Journal of immunology research 2020 (2020)
Hibah Shaath, Radhakrishnan Vishnubalaji, Eyad Elkord, Nehad M Alajez
Single-Cell Transcriptome Analysis Highlights a Role for Neutrophils and Inflammatory Macrophages in the Pathogenesis of Severe COVID-19. Cells 9 (11) (2020)
Reem Saleh, Eyad Elkord
Exosomes: Biological Carriers and Promising Tools for Cancer Immunotherapy. Vaccines 8 (3) (2020)
Salman M Toor, Rowaida Z Taha, Varun Sasidharan Nair, Reem Saleh, Khaled Murshed, Mohamed Abu Nada, Eyad Elkord
Differential gene expression of tumor-infiltrating CD33+ myeloid cells in advanced- versus early-stage colorectal cancer. Cancer immunology, immunotherapy : CII 70 (3) (2020)
Reem Saleh, Rowaida Z Taha, Varun Sasidharan Nair, Salman M Toor, Nehad M Alajez, Eyad Elkord
Transcriptomic Profiling of Circulating HLA-DR- Myeloid Cells, Compared with HLA-DR+ Myeloid Antigen-presenting Cells. Immunological investigations 50 (8) (2020)
Salman M Toor, Reem Saleh, Varun Sasidharan Nair, Rowaida Z Taha, Eyad Elkord
T-cell responses and therapies against SARS-CoV-2 infection. Immunology 162 (1) (2020)
Varun Sasidharan Nair, Reem Saleh, Salman M Toor, Rowaida Z Taha, Ayman A Ahmed, Mohamed A Kurer, Khaled A Murshed, Mohamed Abu Nada, Eyad Elkord
Epigenetic regulation of immune checkpoints and T cell exhaustion markers in tumor-infiltrating T cells of colorectal cancer patients. Epigenomics 12 (21) (2020)
Hadeel Kheraldine, Balsam Rizeq, Eyad Elkord, Semir Vranic, Ala-Eddin Al Moustafa
SARS-CoV-2 Infection and Lung Cancer: Potential Therapeutic Modalities. Cancers 12 (8) (2020)
Varun Sasidharan Nair, Reem Saleh, Salman M Toor, Rowaida Z Taha, Ayman A Ahmed, Mohamed A Kurer, Khaled Murshed, Nehad M Alajez, Mohamed Abu Nada, Eyad Elkord
Transcriptomic profiling disclosed the role of DNA methylation and histone modifications in tumor-infiltrating myeloid-derived suppressor cell subsets in colorectal cancer. Clinical epigenetics 12 (1) (2020)
Reem Saleh, Salman M Toor, Rowaida Z Taha, Dana Al-Ali, Varun Sasidharan Nair, Eyad Elkord
DNA methylation in the promoters of PD-L1, MMP9, ARG1, galectin-9, TIM-3, VISTA and TGF-β genes in HLA-DR- myeloid cells, compared with HLA-DR+ antigen-presenting cells. Epigenetics 15 (12) (2020)
Varun Sasidharan Nair, Reem Saleh, Rowaida Z Taha, Salman M Toor, Khaled Murshed, Ayman A Ahmed, Mohamed A Kurer, Mohamed Abu Nada, Fares Al Ejeh, Eyad Elkord
Differential gene expression of tumor-infiltrating CD4+ T cells in advanced versus early stage colorectal cancer and identification of a gene signature of poor prognosis. Oncoimmunology 9 (1) (2020)
Salman M Toor, Varun Sasidharan Nair, Eyad Elkord
Editorial of Harnessing the Power of T Cells: The Promising Hope for a Universal Influenza Vaccine. Vaccines 8 (3) (2020)
Reem Saleh, Salman M Toor, Eyad Elkord
Targeting TIM-3 in solid tumors: innovations in the preclinical and translational realm and therapeutic potential. Expert opinion on therapeutic targets 24 (12) (2020)
Reem Saleh, Salman M Toor, Dana Al-Ali, Varun Sasidharan Nair, Eyad Elkord
Blockade of PD-1, PD-L1, and TIM-3 Altered Distinct Immune- and Cancer-Related Signaling Pathways in the Transcriptome of Human Breast Cancer Explants. Genes 11 (6) (2020)
S M Toor, V Sasidharan Nair, G Pfister, Eyad Elkord
Effect of pembrolizumab on CD4+ CD25+ , CD4+ LAP+ and CD4+ TIM-3+ T cell subsets. Clinical and experimental immunology 196 (3) (2019)
Reem Saleh, Rowaida Z Taha, Varun Sasidharan Nair, Nehad M Alajez, Eyad Elkord
PD-L1 Blockade by Atezolizumab Downregulates Signaling Pathways Associated with Tumor Growth, Metastasis, and Hypoxia in Human Triple Negative Breast Cancer. Cancers 11 (8) (2019)
Mohammad A I Al-Hatamleh, Engku Nur Syafirah Engku Abd Rahman, Jennifer C Boer, Emmanuel Ibarboure, Jean-Luc Six, Xin Chen, Eyad Elkord, Magdalena Plebanski, Rohimah Mohamud
Synergistic Effects of Nanomedicine Targeting TNFR2 and DNA Demethylation Inhibitor-An Opportunity for Cancer Treatment. Cells 9 (1) (2019)
Varun Sasidharan Nair, Salman M Toor, Ghina Taouk, Gerald Pfister, Khalid Ouararhni, Nehad M Alajez, Eyad Elkord
Pembrolizumab Interferes with the Differentiation of Human FOXP3+-Induced T Regulatory Cells, but Not with FOXP3 Stability, through Activation of mTOR. Journal of immunology (Baltimore, Md. : 1950) 204 (1) (2019)
Hibah Shaath, Salman M Toor, Varun Sasidharan Nair, Eyad Elkord, Nehad M Alajez
Transcriptomic Analyses Revealed Systemic Alterations in Gene Expression in Circulation and Tumor Microenvironment of Colorectal Cancer Patients. Cancers 11 (12) (2019)
Pramod Darvin, Varun Sasidharan Nair, Eyad Elkord
PD-L1 Expression in Human Breast Cancer Stem Cells Is Epigenetically Regulated through Posttranslational Histone Modifications. Journal of oncology 2019 (2019)
Varun Sasidharan Nair, Haytham El Salhat, Rowaida Z Taha, Anne John, Bassam R Ali, Eyad Elkord
DNA methylation and repressive H3K9 and H3K27 trimethylation in the promoter regions of PD-1, CTLA-4, TIM-3, LAG-3, TIGIT, and PD-L1 genes in human primary breast cancer. Clinical epigenetics 10 (2018)
Salman M Toor, Eyad Elkord
Therapeutic prospects of targeting myeloid-derived suppressor cells and immune checkpoints in cancer. Immunology and cell biology 96 (9) (2018)
Eyad Elkord, Varun Sasidharan Nair
T-Regulatory Cells in Health and Disease. Journal of immunology research 2018 (2018)
Varun Sasidharan Nair, Salman M Toor, Rowaida Z Taha, Hibah Shaath, Eyad Elkord
DNA methylation and repressive histones in the promoters of PD-1, CTLA-4, TIM-3, LAG-3, TIGIT, PD-L1, and galectin-9 genes in human colorectal cancer. Clinical epigenetics 10 (1) (2018)
Asma A Elashi, Varun Sasidharan Nair, Rowaida Z Taha, Hibah Shaath, Eyad Elkord
DNA methylation of immune checkpoints in the peripheral blood of breast and colorectal cancer patients. Oncoimmunology 8 (2) (2018)
Pramod Darvin, Salman M Toor, Varun Sasidharan Nair, Eyad Elkord
Immune checkpoint inhibitors: recent progress and potential biomarkers. Experimental & molecular medicine 50 (12) (2018)
Varun Sasidharan Nair, Salman M Toor, Bassam R Ali, Eyad Elkord
Dual inhibition of STAT1 and STAT3 activation downregulates expression of PD-L1 in human breast cancer cells. Expert opinion on therapeutic targets 22 (6) (2018)
S M Toor, A S Syed Khaja, I Alkurd, Eyad Elkord
In-vitro effect of pembrolizumab on different T regulatory cell subsets. Clinical and experimental immunology 191 (2) (2017)
Salman M Toor, Eyad Elkord
Comparison of Myeloid Cells in Circulation and in the Tumor Microenvironment of Patients with Colorectal and Breast Cancers. Journal of immunology research 2017 (2017)
Salman M Toor, Azharuddin Sajid Syed Khaja, Haytham El Salhat, Issam Faour, Jihad Kanbar, Asif A Quadri, Mohamed Albashir, Eyad Elkord
Myeloid cells in circulation and tumor microenvironment of breast cancer patients. Cancer immunology, immunotherapy : CII 66 (6) (2017)

Eyad Elkord.css-eqlu8i{font-size:small;padding-left:4px;} (E Elkord)

Publication Activity (10 Years)

Top Topics

Top Venues

Eyad Elkord (E Elkord)